India bans wellness wonder <i>ashwagandha's </i>leaf products on health risk
The move could disrupt formulations in India’s $38.77 billion nutraceuticals industry, where ashwagandha is a key product with its market estimated at $928.5 million in 2026.
Original Source
Read the full article at Livemint →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.